Appointments at Premier Research, Porsolt and BioStorage – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Contract research organization Clinical trial Pharmaceutical industry

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Premier Research, Porsolt and BioStorage.

Premier Research Group​ has appointed Charlene Sanders ​as vice president (VP), global regulatory affairs and pediatric strategic consulting. Sanders has previously worked at Merck & Co, Duramed Research and Sankyo Pharma Development during a 15 year career.

David Pushett ​has joined Porsolt​ as director of global business development. Pushett has worked in biotech for 15 years at companies including periods at PsychoGenics and MindGenix.

Clinical Trials of America​ has named Pamela Pannier​ as its clinical operations director. During an 18 year career in clinical research Pannier has worked at Advanced Clinical Research and Coordinators Plus.

Gregory Swanberg​ has been hired by BioStorage Technologies ​to serve as its CEO. Swanberg replaces company co-founder John Mills ​who remains as chairman of the board. Before joining BioStorage Swanberg worked at Pfizer, Merck, Genentech, Novartis and Eli Lilly.

Logistics service provider Longistics​ has promoted Berry Petty Jr​ to the positions of VP and general manager of the transportation division. Petty joined Longistics in 1998 and previously worked as a controller.

Richard Hawkins​, the founder of contract research organisation (CRO) Pharmaco​, has joined the board of directors at Savara​. In addition to Pharmaco Hawkins has worked at Sensus Drug Development, Covance Biotechnology Services and LoopOne.

Business service provider DDN​ has appointed Steve Schommer ​as VP, logistics and supply chain. Schommer worked at UPS for 25 years before taking the position of CEO at Wavechange Logistics.

Steven Klosk​, president and CEO of Cambrex​, has been awarded for ‘Embracing Innovation’, both personally and professionally, by the New York Law School​.

ShangPharma ​has named Benson Tsang​ as a member of its board of directors and audit committee. Kevin Penghui Chen​, chief financial and operating officer at ShangPharma, will resign as a member of the audit committee but remain on the board.

Related topics Markets & Regulations

Related news

Show more